Serum IL-17 levels can be diagnostic for gastric cancer.

---

Atıf İçin Kopyala

Karabulut M., Afsar C. U., Serimez M., Karabulut S.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, cilt.24, sa.4, ss.1601-1609, 2019 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 24 Sayı: 4
• Basım Tarihi: 2019
• Dergi Adı: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.1601-1609
• İstanbul Üniversitesi Adresli: Evet

Özet

Purpose: Gastric cancer (GC) is one of the most common malignancies worldwide. Although it has been strongly associated with immunopathology, IL-17 also has an important role in host defense so this makes it more important in GC, which is a microorganism-related cancer. The aim of this study was to determine the clinical significance of the serum levels of IL-17 in GC patients.